Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $57.77 +3.57%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CRMT, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Trip.com Group (TCOM) Misses Q1 EPS by 41c
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
